NEW YORK – Qiagen on Thursday said that it has launched a “Digital Insights Partnership” program designed to expand the market for its bioinformatics products through various third-party collaborations and deals.
The Montgomery County biotech joins a handful of other local companies to recently debut on the public markets.
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your feedback session with BHI EIRs here: www.tinyurl.com/EIRfeedback. These take place by videoconference via Zoom. Pre-registration and forwarding of a power point deck one week before the session is required. For questions, more information, or to be added to the wait list, please contact BHI.
Please review the available slots below and click on the button to register. Thank you!
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your feedback session with BHI EIRs here: www.tinyurl.com/EIRfeedback. These take place by videoconference via Zoom. Pre-registration and forwarding of a power point deck one week before the session is required. For questions, more information, or to be added to the wait list, please contact BHI.
Please review the available slots below and click on the button to register. Thank you!
Troy A LeMaile-Stovall, CEO and Executive Director of TEDCO, joins Rich Bendis BioTalk to discuss his background, the local ecosystem, and their vision for the future here in Maryland
Listen now via Apple http://apple.co/3tMsGQ4 , Google http://bit.ly/372QPs5 , http://spoti.fi/3tV2vXI , and TuneIn http://bit.ly/3aOuuzC.
Last month, biotechnology company United Therapeutics began tearing down the historic Elion-Hitchings building in Research Triangle Park, a Mid-Century, Brutalist structure built by the famed architect Paul Rudolph.
While the move was met with dismay from architecture lovers, the demolition could portend a large expansion on the building’s 132-acre property in the coming years.
Image: United Therapeutics currently employs more than 400 people in Research Triangle Park. UNITED THERAPEUTICS.
Johns Hopkins University led all U.S. universities in research and development spending for the 41st consecutive year in fiscal year 2019, spending a record $2.917 billion.
The university’s total R&D expenditure for fiscal year 2019—the most recent year for which nationwide data is available—rose 9.6% from the previous year, according to the annual National Science Foundation report on higher education R&D.
Image: https://hub.jhu.edu
Creating university communities of innovation is AURP’s core expertise. And as university innovation communities evolve, AURP announces university innovation community builders’ latest professional development opportunity — Innovation U Virtual Seminars. We’ll be featuring information and knowledge about the latest trends in innovation and university districts — the why, the how-to and “the who is doing it and where?”
Germantown, MD, February, 9, 2021 – Seraxis, a biotech company developing a cell replacement therapy for insulin-dependent diabetes today announced the successful closing of a $40M Series C private financing round. The financing was led by Eli Lilly and Company, with participation from Frazier Healthcare Partners, Polaris Ventures, JDRF T1D Fund, and other investors.
(Reuters) – Genetic testing specialist Qiagen’s Chief Executive Thierry Bernard said the company is interested in organic growth and “bolt-on” acquisitions, when asked about recent merger and acquisition speculation during a results conference call on Wednesday.